Southwest Oncology Group

西南肿瘤组

基本信息

批准号：
7405339
负责人：
LAWRENCE E FLAHERTY
金额：
$ 21.72万
依托单位：
WAYNE STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1978
资助国家：
美国
起止时间：
1978-01-01 至 2009-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7405339
关键词：
Academic Medical Centers Academy Address Adenovirus p53 Adherence Adjuvant Adjuvant Therapy Adverse event African American Agreement All Sites American American Association of Cancer Research American Society of Clinical Oncology Amifostine Anaplastic astrocytoma Androgen Antagonists Androgens Antithymoglobulin Appointment Area Arts Authorship Award Basic Science Biological Preservation Biology Bladder Blinded Blood Books Brain Breast Calendar Cancer Center Cancer Control Cancer Patient Carbon Dioxide Carboplatin Cardiovascular Surgical Procedures Caring Carmustine Chairperson Chemoprevention Chest Chin Cisplatin Clinic Clinical Clinical Nurse Specialists Clinical Oncology Clinical Pathology Clinical Practice Guideline Clinical Protocols Clinical Research Clinical Research Associate Clinical Trials Clinical Trials Cooperative Group Clinical Trials Database Code Color Combined Modality Therapy Communication Communities Community Clinical Oncology Program Comprehensive Cancer Center Conduct Clinical Trials Consent Consent Forms Cytogenetics Data Data Collection Data Quality Data Reporting Defective spinal cord development Dental Diagnostic Diagnostic tests Discipline Discipline of Nursing Disease Doctor of Medicine Doctor of Philosophy Documentation Dysmyelopoietic Syndromes Economics Elderly Electronic Mail Eligibility Determination Enrollment Ensure Estramustine Estramustine/Etoposide Evaluation Exercise F 4 Faculty Florida Flow Cytometry Fluorouracil Flutamide Follow-Up Studies Foundations Future GRP gene Gemcitabine/Paclitaxel Genitourinary system Geographic Locations Glioma Glutamine Goals Grant Group Meetings Guidelines Hawaii Head Head and Neck Cancer Head and neck structure Health Fairs Height Hematology Home environment Hospitals Hour Housing Human Genetics Human Resources Image Immunotherapy Individual Inpatients Institutes Institution Interferons Interleukin-4 International Internet Intervention Intranet Intravenous Investigation Investigational Drugs Japan Journals Label Laboratories Larynx Lasers Lead Leadership Life Lung Lymph Lymphoma Maintenance Malignant Neoplasms Malignant Squamous Cell Neoplasm Malignant neoplasm of lung Malignant neoplasm of prostate Manuscripts Medical Medical Oncologist Medical Oncology Medical Records Medicine Melanocytic nevus Mesothelioma Metastatic Melanoma Michigan Minority Mole the mammal Monitor Mouth Carcinoma Multiple Myeloma Names Nature Neoadjuvant Therapy New England Non-Small-Cell Lung Carcinoma Notification Numbers Nurse Administrator Nurse Practitioners Nurses Oncologic Nursing Oncology Nurse Operative Surgical Procedures Organ Oropharyngeal Outpatients Paclitaxel Pancreas Paper Participant Pathology Patient Appointment Patients Patients&apos Rooms Performance Performance Status Perioperative Personal Computers Pharmaceutical Preparations Pharmacotherapy Pharmacy facility Phase Phase II Clinical Trials Phase II/III Trial Phase III Clinical Trials Physician Assistants Physicians Physicians&apos Offices Physics Pilot Projects Placebos Play Policies Pontine structure Population Positioning Attribute Positron-Emission Tomography Preparation Principal Investigator Printing Procedures Process Progress Reports Prostate Protocols documentation Psychological reinforcement Publications Published Comment Publishing Pulmonary Tuberculosis Radiation Radiation Oncology Radiology Specialty Randomized Controlled Clinical Trials Records Recruitment Activity Recurrence Refractory Regulation Relapse Reporting Research Research Ethics Committees Research Personnel Research Priority Resectable Resources Risk Role Safety Salmon Sampling Schedule Science Secure Security Side Site Societies Solid Source Southwest Oncology Group Sparrows Squamous Cell Staging Surgical Oncologist Surgical Oncology Surgical Pathology Suspension substance Suspensions TP protocol Telefacsimile Test Result Therapeutic Therapy Clinical Trials Thoracic Oncology Time Topotecan Toxic effect Training Transfusion Translating Translational Research Translations Treatment Protocols Triage Tumor Biology United States Department of Veterans Affairs Universities University Hospitals Update Upper arm Urology Veterans Hospitals Visit Weight Withdrawal Woman Women&apos s Health Wood material Work Xoladex abstracting anticancer research awake base cancer genetics cancer research center director chemotherapy compound 351 A data management day demographics deprivation dosage expectation experience follow-up gastrointestinal gene therapy hydroxyurea interest leukemia leukemia/lymphoma lomustine/procarbazine/vincristine melanoma member meningioma multidisciplinary named group neuro-oncology novel oncology oxaliplatin pancreatic neoplasm pilot trial posters programs prospective quality assurance repository research facility research study response sarcoma statistical center symposium translational approach tumor ward

项目摘要

DESCRIPTION (provided by applicant): Wayne State University (WSU) has been an active institutional member of the Southwest Oncology Group for over 30 years, enrolling over 4000 patients onto clinical trials. Over these years, our faculty have played an important role in support of SWOG, by providing leadership in the administrative and scientific functions of SWOG, and also by meeting and exceeding patient accrual goals in a continuous and consistent manner. Thus, WSU has remained in the first quartile of institution's performance evaluation conducted by SWOG in each of the last five years. The clinical research program in cancer at WSU has been organized along the lines of multidisciplinary disease oriented studies and in a manner that resembles the organ committee orientation of SWOG. Thus, our faculty's representation in scientific SWOG committees is constituted by individuals with expertise and commitment toward those areas of research. Accordingly, the translation of ideas into SWOG studies as well as the incorporation of SWOG studies and those of NCI designated high priority trials into WSU treatment priorities, are easily facilitated. In addition, the demographics of our region and the commitment of investigators to make clinical trials available to all patients, is clearly identified in our recruitment of minorities (27%) and women (61%) into SWQG clinical trials. The SWOG membership in WSU and the diversity of disciplinary involvement by our faculty has continued to grow over the years. To date over 100 WSU members are currently serving on over 40 committees. Similarly, 50 SWOG studies list a WSU member as a study primary coordinator or co-coordinator since the last competing application was submitted. Fifth three abstracts and 56 manuscripts have had WSU faculty as primary or co-authors. Six WSU physician faculty and 3 nurses hold 14 committee administrative roles. Since the last competitive renewal WSU has been awarded NCl supplemental grants for chemoprevention and minority recruitment. Dr. Lawrence Flaherty, a SWOG member since 1986 and Vice-Chairman of the SWOG Melanoma Committee, has been the Principal Investigator since 1996 and has maintained the prominence of WSU as a SWOG member institution.

描述（由申请人提供）：韦恩州立大学 (WSU) 30 多年来一直是西南肿瘤学组的活跃机构成员，已招募了 4000 多名患者参加临床试验。这些年来，我们的教职员工在 SWOG 的支持中发挥了重要作用，在 SWOG 的行政和科学职能方面提供领导，并以持续一致的方式满足和超越患者应计目标。因此，在过去五年里，WSU 每年都在 SWOG 进行的机构绩效评估中名列前四位。 WSU 的癌症临床研究项目是按照多学科疾病导向研究的方式组织的，其方式类似于 SWOG 的器官委员会导向。因此，我们的 SWOG 科学委员会中的教师代表是由具有专业知识并致力于这些研究领域的个人组成的。因此，将想法转化为 SWOG 研究以及将 SWOG 研究和 NCI 指定的高优先级试验纳入 WSU 治疗优先事项都很容易。此外，我们在招募少数族裔 (27%) 和女性 (61%) 参加 SWQG 临床试验时明确表明了我们地区的人口统计数据以及研究人员向所有患者提供临床试验的承诺。多年来，华盛顿州立大学的 SWOG 会员资格以及我们教师参与学科的多样性不断增长。迄今为止，已有 100 多名 WSU 成员在 40 多个委员会任职。同样，自上次提交竞争申请以来，50 项 SWOG 研究将 WSU 成员列为研究主要协调员或联合协调员。第五，三篇摘要和 56 篇手稿由 WSU 教师作为主要或共同作者。华盛顿州立大学的 6 名医师和 3 名护士担任 14 个委员会行政职务。自上次竞争性续签以来，WSU 已获得 NCl 补充拨款，用于化学预防和少数族裔招募。 Lawrence Flaherty 博士自 1986 年起成为 SWOG 成员，并担任 SWOG 黑色素瘤委员会副主席，自 1996 年起一直担任首席研究员，并保持了 WSU 作为 SWOG 成员机构的突出地位。